What is the immediate management for a patient with symptomatic syncope and a history of Brugada syndrome in the Emergency Room (ER)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Immediate ER Management of Symptomatic Syncope in Brugada Syndrome

Admit the patient immediately to a monitored bed with continuous telemetry and prepare for ICD evaluation, as syncope in Brugada syndrome is presumed arrhythmic until proven otherwise. 1

Initial Assessment and Stabilization

Immediate Actions

  • Place on continuous cardiac telemetry monitoring to detect ventricular arrhythmias or bradyarrhythmias 2, 3
  • Obtain 12-lead ECG with high electrode positioning (second and third intercostal spaces) to confirm spontaneous type 1 Brugada pattern: coved ST-segment elevation ≥2 mm in V1 and/or V2 with negative T-waves 1, 4
  • Check temperature and treat fever aggressively with antipyretics if present, as fever can acutely precipitate cardiac arrest in Brugada syndrome 1, 4, 5
  • Review all medications immediately and discontinue sodium channel blockers, QT-prolonging drugs, psychotropic agents, and anesthetic agents that may trigger ventricular fibrillation 1, 4, 5

Critical History Elements

  • Document syncope characteristics: prodromal symptoms (typically absent or brief in arrhythmic syncope), position during event (supine or during exertion suggests cardiac cause), witness account of seizure-like activity, and recovery phase 1, 6
  • Identify high-risk features: family history of sudden cardiac death, previous cardiac arrest, recurrent syncope episodes, and syncope during sleep or at rest 1, 4
  • Assess for alternative causes: recent alcohol excess, cocaine use, or situational triggers that might suggest vasovagal syncope 1, 5

Physical Examination Priorities

  • Complete cardiovascular examination for structural heart disease, murmurs, or signs of heart failure 6
  • Orthostatic vital signs to exclude orthostatic hypotension as alternative diagnosis 6
  • Neurological examination to identify focal deficits that would suggest alternative diagnosis 1

Risk Stratification and Disposition

High-Risk Features Mandating Admission

This patient meets Class I criteria for ICD evaluation based on spontaneous type 1 ECG pattern with recent syncope presumed due to ventricular arrhythmia 1, 4

The annual arrhythmic event rate in Brugada patients with syncope is 3.2% compared to 13.5% in cardiac arrest survivors and 1% in asymptomatic patients 4, 5

Diagnostic Testing in ER

  • Targeted laboratory tests only: electrolytes, renal function if dehydration suspected, but avoid comprehensive panels without indication 6
  • Echocardiography to exclude structural heart disease if not previously documented 1, 6
  • Do NOT order: routine brain imaging (CT/MRI), EEG, or carotid ultrasound unless focal neurological findings present 1, 6

Definitive Management Plan

ICD Implantation (Class I Recommendation)

ICD implantation is recommended if meaningful survival greater than 1 year is expected, as this is the only proven therapy to prevent sudden cardiac death 1, 4, 5

Alternative Management if ICD Declined or Contraindicated

  • Quinidine (Class I recommendation for patients who decline or are not candidates for ICD) 1, 4
  • Catheter ablation of right ventricular outflow tract as alternative option 1, 5

Role of Electrophysiology Study

EP study with programmed ventricular stimulation may be considered (Class IIb) for further risk stratification, though its utility remains debated 1

However, implantable loop recorder (ILR) can be useful in select cases where syncope mechanism remains unclear, particularly to exclude vasovagal syncope or bradyarrhythmias before committing to ICD 2, 3

Critical Pitfalls to Avoid

Common Diagnostic Errors

  • Do not assume vasovagal syncope even if patient is young or has prodromal symptoms—arrhythmic syncope in Brugada often has minimal or absent prodrome 3
  • Do not discharge without telemetry monitoring even if patient appears stable, as ventricular arrhythmias can occur unpredictably 4, 3
  • Do not order drug-induced type 1 pattern testing in ER if spontaneous type 1 pattern already present—this is unnecessary and potentially dangerous 1

Medication Safety

  • Avoid: sodium channel blockers (Class IA and IC antiarrhythmics), certain psychotropic medications, cocaine, and excessive alcohol 1, 4, 5
  • Treat fever immediately as it can unmask or worsen Brugada pattern and precipitate ventricular fibrillation 1, 4, 5

Disposition and Follow-Up

Admission Criteria (All Met in This Case)

  • Spontaneous type 1 Brugada pattern with syncope requires admission to monitored bed 1, 4
  • Cardiology/electrophysiology consultation for ICD evaluation during hospitalization 1, 4
  • Family screening should be initiated with genetic counseling (Class IIb recommendation) 1, 4

If ICD Implanted

  • Monitor for device complications: inappropriate shocks, infection, psychological impact 7
  • Consider quinidine or ablation if recurrent ICD shocks occur (Class I recommendation) 1, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Use of implantable loop recorders in patients with Brugada syndrome and suspected risk of ventricular arrhythmia.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2012

Research

Brugada syndrome and syncope: a practical approach for diagnosis and treatment.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2021

Guideline

Management of Symptomatic Syncope in Brugada Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Brugada Syndrome Treatment and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Initial Management of Syncope

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.